# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-550284
Filing Date
2016-04-21
Accepted
2016-04-21 16:21:49
Documents
4
Period of Report
2016-05-19
Effectiveness Date
2016-04-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d142610ddef14a.htm | DEF 14A | 955088
2 | GRAPHIC | g142610g09k79.jpg | GRAPHIC | 27905
3 | GRAPHIC | g142610newepc.jpg | GRAPHIC | 255879
4 | GRAPHIC | g142610newepc2.jpg | GRAPHIC | 181371
| Complete submission text file | 0001193125-16-550284.txt |  | 1597190

Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50865 | Film No.: 161584280
SIC: 2834 Pharmaceutical Preparations